Ligand fishing using new chitosan based functionalized Androgen Receptor magnetic particles

Journal of Pharmaceutical and Biomedical Analysis

Volumn 127, Issue , 2016, Pages 129-135

  Marszałł, Michał Piotr ^a   Sroka, Wiktor Dariusz ^a   Sikora, Adam ^a   Chełminiak, Dorota ^b   Ziegler Borowska, Marta ^b   Siódmiak, Tomasz ^a   Moaddel, Ruin ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Androgen receptor; Antiandrogens; Chitosan; Ligand fishing; Magnetic beads

Indexed keywords

AMMONIUM ACETATE; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; BICALUTAMIDE; CARBOXYLIC ACID; CHITOSAN; DEXAMETHASONE; FLUTAMIDE; HYDROXYFLUTAMIDE; LEVONORGESTREL; LIDOCAINE; LIGAND; MAGNETIC NANOPARTICLE; PHTHALIC ACID DIBUTYL ESTER; SILICON DIOXIDE; ANTIANDROGEN; IMMOBILIZED PROTEIN; MAGNETITE NANOPARTICLE; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; LIGAND BINDING; PH; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; PROCEDURES; SURFACE PROPERTY;

ANDROGEN ANTAGONISTS; CHITOSAN; DRUG DISCOVERY; IMMOBILIZED PROTEINS; LIGANDS; MAGNETITE NANOPARTICLES; PROTEIN BINDING; RECEPTORS, ANDROGEN; SURFACE PROPERTIES;

EID: 84964875186     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2016.04.013     Document Type: Article

References (28)

1. [1] Eileen Tan, M.H., Li, J., Xu, H.E., Melcher, K., Yong, E., Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol. Sin. 36 (2015), 3–23.
2. [2] Kaufman, J.M., Vermeulen, A., The decline in androgen levels in elderly men and its clinical and therapeutical implication. Endocr. Rev. 26 (2005), 833–876.
3. [3] Rosario, E.R., Pike, C.J., Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. Brain Res. Rev. 57 (2008), 444–453.
4. [4] Chena, Y., Clegga, N.J., Scherb, H.I., Antiandrogens and androgen depleting therapies in prostate cancer: novel agents for an established target. Lancet Oncol. 10 (2009), 981–991.
5. [5] Kojima, S., Suzuki, H., Akakura, K., Shimbo, M., Ichikawa, T., Ito, H., Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy. J. Urol. 171 (2004), 679–683.
6. [6] Nique, F., Hebbe, S., Peixoto, C., Annoot, D., Lefrançois, J.M., Duval, E., Michoux Triballeau, L.L.N., Lemoullec, J.M., Mollat, P., Thauvin, M., Prangé, T., Minet, D., Clément-Lacroix, P., Robin-Jagerschmidt, C., Fleury, D., Guédin, D., Deprez, P., Discovery of diarylhydantoins as new selective androgen receptor modulators. J. Med. Chem. 55 (2012), 8225–8235.
7. [7] Nique, F., Hebbe, S., Triballeau, N., Peixoto, C., Lefrançois, J.M., Jary, H., Alvey, L., Manioc, M., Housseman, C., Klaassen, H., Van Beeck, K., Guédin, D., Namour, F., Minet, D., Van der Aar, E., Feyen, J., Fletcher, S., Blanqué, R., Robin-Jagerschmidt, C., Deprez, P., Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator. J. Med. Chem. 55 (2012), 8236–8247.
8. [8] Freyberger, A., Ahr, H.J., Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor. Toxicology 195 (2004), 113–126.
9. [9] Freyberger, A., Weimer, M., Tran, H.S., Ahr, H.J., Assessment of a recombinant androgen receptor binding assay: initial steps towards validation. Reprod. Toxicol. 30 (2010), 2–8.
10. [10] Féau, C., Arnold, L.A., Kosinski, A., Guy, R.K., A high-throughput ligand competition binding assay for the androgen receptor and other nuclear receptors. J. Biomol. Screen. 1 (2009), 43–48.
11. [11] Turek-Etienne, T.C., Small, E.C., Soh, S.C., Xin, T.A., Gaitonde, P.V., Barrabee, E.B., Hart, R.F., Bryant, R.W., Evaluation of fluorescent compound interference in 4 fluorescence polaryzation assays. Biomol. Screen. 2 (2003), 176–184.
12. [12] Nichols, J.S., Parks, D.J., Consler, T.G., Blanchard, S.G., Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal. Biochem. 257 (1998), 112–119.
13. [13] Vanzolini, K.L., Jiang, Z., Zhang, X., Vieira, L.C.C., Corrêa, A.G., Cardoso, C.L., Cass, Q.B., Moaddel, R., Acetylcholinesterase immobilized capillary reactors coupledto protein coated magnetic beads: a new tool for plant extract ligand screening. Talanta 116 (2013), 647–652.
14. [14] Wiekhorst, F., Steinhoff, U., Eberbeck, D., Trahms, L., Magnetorelaxometry assisting biomedical applications of magnetic nanoparticles. Pharm. Res. 29:May (5) (2012), 1189–1202.
15. [15] Wubshet, S.G., Brighente, I.M., Moaddel, R., Staerk, D., Magnetic ligand fishing as a targeting tool for HPLC-HRMS-SPE-NMR: α-glucosidase inhibitory ligands and alkylresorcinol glycosides from Eugenia catharinae. J. Nat. Prod. 78:11 (2015), 2657–2665.
16. [16] Singh, N., Ravichandran, S., Spelman, K., Fugmann, S.D., Moaddel, R., The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads. J. Chromatogr. B 968 (2014), 105–111.
17. [17] Moaddel, R., Marszall, M.P., Bighi, F., Yang, Q., Duan, X., Wainer, I.W., Automated ligand fishing using human serum albumin-coated magnetic beads. Anal. Chem. 79 (2007), 5414–5417.
18. [18] de Moraes, M.C., Vanzolini, K.L., Cardoso, C.L., Cass, Q.B., New trends in LC protein ligand screening. J. Pharm. Biomed. Anal. 87 (2014), 155–166.
19. [19] Marszałł, M.P., Buciński, A., Kruszewski, S., Ziomkowska, B., A new approach to determine camptothecin and its analogues affinity to human serum albumin. J. Pharm. Sci. 100 (2011), 1142–1146.
20. [20] Liu, Q., Shi, S., Liu, L., Yang, H., Su, W., Chen, X., Separation and purification ofbovine serum albumin binders from Fructus polygoni orientalis using off-linetwo-dimensional complexation high-speed counter-current chromatographytarget-guided by ligand fishing. J. Chromatogr. A 1304 (2013), 183–193.
21. [21] Marszall, M.P., Moaddel, R., Kole, S., Gandhari, M., Bernier, M., Wainer, I.W., Ligand and protein fishing with heat shock protein 90 coated magnetic beads. Anal. Chem. 80 (2008), 7571–7575.
22. [22] Corchero, J.L., Villaverde, A., Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 27 (2009), 468–476.
23. [23] Mati-Baouche, N., Elchinger, P.H., de Baynast, H., Pierre, G., Delattre, C., Michaud, P., Chitosan as an adhesive. Eur. Polym. J. 60 (2014), 198–212.
24. [24] Kumar, S., Jana, A.K., Dhamija, I., Maiti, M., Chitosan-assisted immobilization of serratiopeptidase on magnetic nanoparticles: characterization and its target delivery. J. Drug Target. 22 (2014), 123–137.
25. [25] Alvarez, S.A., Iyina, A.I., Jauregui, K.M., Hernandez, J.L., Ceniceros, E.P., Cruz, A.Z., Caballero, H.S., Campos, R.G., Isolation and immobilization of influenza virus-specific N-SA-α-2,3-Gal receptors using magnetic nanoparticles coated with chitosan and Maackia amurensis lectin. Appl. Biochem. Biotechnol. 174 (2014), 1945–1958.
26. [26] Ziegler-Borowska, M., Chełminiak, D., Siódmiak, T., Sikora, A., Marszałł, M.P., Kaczmarek, H., Synthesis of new chitosan coated magnetic nanoparticles with surface modified with long-distanced amino groups as a support for bioligands binding. Mater. Lett. 132 (2014), 63–65.
27. [27] Ziegler-Borowska, M., Siódmiak, T., Chełminiak, D., Cyganiuk, A., Marszałł, M.P., Magnetic nanoparticles with surfaces modified with chitosan-poly[N-benzyl-2-(methacryloxy)-N,N-dimethylethanaminium bromide] for lipase immobilization. Appl. Surf. Sci. 288 (2014), 641–648.
28. [28] Ziegler-Borowska, M., Chełminiak, D., Kaczmarek, H., Kaczmarek-Kędziera, A., Effect of side substituents on thermal stability of the modified chitosan and its nanocomposites with magnetite. J. Therm. Anal. Calorim., 2016, 1–14.